FDA Invites Public to Suggest Pediatric Drug/Biologic Products for Review

Summary

The FDA is seeking nominations for specific drugs or biologics to be reviewed by its Pediatric Subcommittee, with the goal of improving pediatric product development and providing a platform for companies to share their plans and receive feedback from the committee.